Insider · CIK 0001340855
Jules Haimovitz
Files at ARMP (Armata Pharmaceuticals, Inc.), INVA (Innoviva, Inc.). First filing -, latest -.
Jules Haimovitz files SEC Form 4 as director at ARMP (Armata Pharmaceuticals, Inc.), and also at INVA (Innoviva, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jules Haimovitz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | INVA Innoviva, Inc. | AGrant or award Common Stock | +9,786 | $0.00 | $0 | 152,692 | May 6, 2026 |
| May 4, 2026 | INVA Innoviva, Inc. | AGrant or award Non-statutory Stock Optionderivative | +10,000 | $0.00 | $0 | 10,000 | May 6, 2026 |
| Mar 9, 2026 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +25,640 | $0.00 | $0 | 25,640 | Mar 11, 2026 |
| May 19, 2025 | INVA Innoviva, Inc. | AGrant or award Common Stock | +12,077 | $0.00 | $0 | 142,906 | May 21, 2025 |
| May 19, 2025 | INVA Innoviva, Inc. | AGrant or award Non-statutory Stock Optionderivative | +10,000 | $0.00 | $0 | 10,000 | May 21, 2025 |
| Feb 5, 2025 | ARMP Armata Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +54,343 | $0.00 | $0 | 54,343 | Feb 7, 2025 |
Questions about Jules Haimovitz
Answered from the filings on this page, as of the latest one.
Is Jules Haimovitz buying or selling?
Jules Haimovitz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jules Haimovitz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jules Haimovitz has 0.
Where does Jules Haimovitz file Form 4?
Jules Haimovitz has filed Form 4 at ARMP (Armata Pharmaceuticals, Inc.); INVA (Innoviva, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.